GI Stool Testing Market Projected to Offer Substantial Growth Opportunities, Reaching $1.86 Billion by 2029
Grab 20% Off With Code ONLINE20 On Global market Reports – Evaluate Global Trends, Market Risks, and Competitive Intelligence
What Is the Comparative Market Size of the GI Stool Testing Market Between 2025 and 2029?
The gi stool testing market size has grown strongly in recent years. It will grow from $1.32 billion in 2024 to $1.41 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to rising prevalence of gastrointestinal diseases, increasing awareness of gut health, increasing adoption of automated systems, growing disposable income, growing geriatric population.
The gi stool testing market size is expected to see strong growth in the next few years. It will grow to " $1.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing need for efficient diagnostic instruments, increasing prevalence of colorectal cancer, rising healthcare expenditure, rising consumption of fast food, growing emphasis on personalized medicine. Major trends in the forecast period include innovative diagnostic technologies, molecular diagnostics, advancements in biologics, personalized medicine, strategic collaboration.
Get your free report sample today:
What Are the Underlying Growth Drivers for the GI Stool Testing Market?
The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the GI stool testing market going forward. Gastrointestinal disorders refer to conditions affecting the digestive system, including the stomach, intestines, and related organs, causing symptoms such as nausea, diarrhea, constipation, and abdominal pain. The rise in gastrointestinal disorders is largely due to poor dietary habits, as increased consumption of processed foods, high sugar intake, and low-fiber diets disrupt gut microbiota, weaken digestive health, and contribute to conditions such as acid reflux, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). GI stool testing is required for gastrointestinal disorders to detect infections, inflammation, or digestive imbalances, as it helps identify pathogens (bacteria, viruses, parasites), markers of gut inflammation, and digestive enzyme deficiencies, enabling accurate diagnosis and targeted treatment. For instance, in September 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that between 2024 and 2025, NoroSTAT-participating states reported 1,676 norovirus outbreaks, marking a significant rise from the 729 outbreaks recorded during the same period last season. Therefore, the increasing prevalence of gastrointestinal disorders drives the growth of the GI stool testing market.
What Are the Major Segments Defining the Structure of the GI Stool Testing Market?
The gi stool testingmarket covered in this report is segmented –
1) By Type: Immunoassay Test; Molecular Diagnostic Test; Chromatography-Based Test; Microbiological Culture Test; Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Sample Type: Fecal Samples; Serum Samples
3) By Equipment: Automated Analyzers; Benchtop Instruments; Portable Devices
4) By Application: Diagnosis Of Gastrointestinal Disorders; Screening For Colorectal Cancer; Monitoring Of Inflammatory Bowel Disease (IBD); Detection Of Gastrointestinal Infections; Evaluation Of Digestive Health
5) By End User: Hospital; Diagnostic Centre And Laboratory; Academic Institution; Research Centre Organization; Homecare; Other End Users
Subsegments:
1) By Immunoassay Test: Rapid Immunoassay; Lateral Flow Assay; Fluorescent Immunoassay
2) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Test (NAAT); Next-Generation Sequencing (NGS)
3) By Chromatography-Based Test: Gas Chromatography (GC); Liquid Chromatography (LC); Thin-Layer Chromatography (TLC)
4) By Microbiological Culture Test: Aerobic Culture; Anaerobic Culture; Selective Media Culture
5) By Enzyme-Linked Immunosorbent Assay (ELISA): Direct ELISA; Indirect ELISA; Sandwich ELISA; Competitive ELISA
What Are the Key Industry Trends Driving Growth in the GI Stool Testing Market?
Major companies operating in the GI stool testing market are focusing on advanced testing technologies, such as comprehensive diagnostic tests, to improve accuracy, speed, and early disease detection. A comprehensive diagnostic test is an advanced medical tool that evaluates multiple health parameters simultaneously, offering a thorough assessment of a condition. For instance, in November 2024, EmeritusDX, a US-based diagnostics company, launched GI Detect, a comprehensive diagnostic test developed to support healthcare providers in identifying gastrointestinal disorders. This cutting-edge test utilizes a single stool swab to detect 26 bacteria, viruses, and parasites associated with digestive system disruptions. With a 24-hour turnaround time, GI Detect enables fast and informed clinical decision-making. In addition to broad pathogen detection, the test also screens for Helicobacter pylori and its virulence factors—VacA, cagA, and babA—as well as common gastrointestinal parasites such as Cryptosporidium, Entamoeba histolytica, and Giardia lamblia. This comprehensive approach ensures accurate and timely diagnosis of gastrointestinal infections.
Which Firms Represent the Competitive Benchmark Within the GI Stool Testing Market?
Major companies operating in the gi stool testing market are Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Meridian BioScience Inc., Diasorin SPA, Helena Laboratories Corporation, ELITechGroup, Genova Diagnostics Inc., Genesis Laboratory Management LLC, US BioTek Laboratories LLC, Doctor's Data Inc., Diagnostic Solutions Laboratory LLC, Serosep Ltd., Atlas Laboratories Ltd., VDI Laboratory LLC, Functional Medical Institute Pvt. Ltd., Walk-In Lab LLC, ScheBo Biotech AG.
Get the detailed gi stool testing market report today
Which Regions Are Driving the Highest Demand in the GI Stool Testing Market?
North America was the largest region in the GI stool testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gi stool testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment